Dynamic process of prostate cancer metastasis to bone

Journal of Cellular Biochemistry

Volumn 91, Issue 4, 2004, Pages 706-717

  Tantivejkul, Kwanchanit ^a   Kalikin, Linda M ^a   Pienta, Kenneth J ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Bone; Cell adhesion; Integrins; Metastasis; Prostate cancer; RhoGTPases; Signal transduction

Indexed keywords

INTEGRIN;

BONE MARROW CELL; BONE METASTASIS; CANCER CELL; CELL ADHESION; CELL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; BONE; BONE TUMOR; CELL MOTION; HUMAN; MALE; METABOLISM; METASTASIS; PATHOLOGY; PROSTATE TUMOR;

BONE AND BONES; BONE NEOPLASMS; CELL ADHESION; CELL MOVEMENT; HUMANS; INTEGRINS; MALE; PROSTATIC NEOPLASMS;

EID: 15944425998     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.10664     Document Type: Review

References (98)

1. Angelucci A, Festuccia C, D'Andrea G, Teti A, Bologna M. 2002. Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators. Biol Chem 383:229-234.
2. Argraves WS, Suzuki S, Arai H, Thompson K, Pierschbacher MD, Ruoslahti E. 1987. Amino acid sequence of the human fibronectin receptor. J Cell Biol 105: 1183-1190.
3. Arthur WT, Burridge K. 2001. RhoA inactivation hy p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 12:2711-2720.
4. Autzen P, Robson CN, Bjartell A, Malcolm AJ, Johnson MI, Neal DE, Hamdy FC. 1998. Bone morphogenetic protein-6 in skeletal metastases from prostate cancer and other common human malignancies. Br J Cancer 78:1219-1223.
5. Barnes J, Anthony CT, Wall N, Steiner MS. 1995. Bone morphogenetic protein-6 expression in normal and malignant prostate. World J Urol 13:337-343.
6. Bello-DeOcampo D, Kleinman HK, Deocampo ND, Webber MM. 2001a. Laminin-1 and α6β1 integrin regulate acinar morphogenesis of normal and malignant human prostate epithelial cells. Prostate 46:142-153.
7. Bello-DeOcampo D, Kleinman HK, Webber MM. 2001b. The role of α6β1 integrin and EGF in normal and malignant acinar morphogenesis of human prostatic epithelial cells. Mutat Res 480-481:209-217.
8. Bentley H, Hamdy FC, Hart KA, Seid JM, Williams JL, Johnstone D, Russell RG. 1992. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer 66: 1159-1163.
9. Bhatti RA, Gadarowski J, Ray P. 1996. Potential role of platelets and coagulation factors in the metastasis of prostatic cancer. Invasion Metastasis 16:49-55.
10. Bonaccorsi L, Carloni V, Muratori M, Salvadori A, Giannini A, Carini M, Serio M, Forti G, Baldi E. 2000. Androgen receptor expression in prostate carcinoma cells suppresses α6β4 integrin-mediated invasive phenotype. Endocrinology 141:3172-3182.
11. Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A. 2001. Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 98:3352-3357.
12. Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ. 2000. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31:578-583.
13. Buck CA. 1995. Adhesion mechanisms controlling cell-cell and cell-matrix interactions during the metastatic process. In Mendelsohn J, Howley PM, Israel MA, Liotta LA (eds): "The Molecular Basis of Cancer." Philadelphia: W.B. Saunders Company, pp 172-205.
14. Chay CH, Cooper CR, Gendernalik JD, Dhanasekaran SM, Chinnaiyan AM, Ruhin MA, Schmaier AH, Pienta KJ. 2002. A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines. Urology 60: 760-765.
15. Cheville JC, Tindall D, Boelter C, Jenkins R, Lohse CM, Pankratz VS, Sebo TJ, Davis B, Blute ML. 2002. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival. Cancer 95:1028-1036.
16. Chopra H, Fligiel SE, Hatfield JS, Nelson KK, Diglio CA, Taylor JD, Honn KV. 1990. An in vivo study of the role of the tumor cell cytoskeleton in tumor cell-platelet-endothelial cell interactions. Cancer Res 50:7686-7696.
17. Chung LW. 2003. Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications. Cancer 97:772-778.
18. Clark EA, King WG, Brugge JS, Symons M, Hynes RO. 1998. Integrin-mediated signals regulated by members of the rho family of GTPases. J Cell Biol 142:573-586.
19. Cooper CR, McLean L, Mucci NR, Poncza P, Pienta KJ. 2000a. Prostate cancer cell adhesion to quiescent endothelial cells is not mediated by β1 integrin subunit. Anticancer Res 20:4159-4162.
20. Cooper CR, McLean L, Walsh M, Taylor J, Hayasaka S, Bhatia J, Pienta KJ. 2000b. Preferential adhesion of prostate cancer cells to bone is mediated by binding to bone marrow endothelial cells as compared to extracellular matrix components in vitro. Clin Cancer Res 6: 4839-4847.
21. Cooper CR, Chay CH, Gendernalik JD, Lee HL, Bhatia J, Taichman RS, McCauley LK, Keller ET, Pienta KJ. 2003. Stromal factors involved in prostate carcinoma metastasis to bone. Cancer 97:739-747.
22. Davis TL, Cress AE, Dalkin BL, Nagle RB. 2001. Unique expression pattern of the α6β4 integrin and laminin-5 in human prostate carcinoma. Prostate 46:240-248.
23. Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T. 1999. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci 112(Pt. 20): 3519-3527.
24. Edlund M, Miyamoto T, Sikes RA, Ogle R, Laurie GW, Farach-Carson MC, Otey CA, Zhau HE, Chung LW. 2001. Integrin expression and usage by prostate cancer cell lines on laminin substrata. Cell Growth Differ 12:99-107.
25. Elgavish A, Prince C, Chang PL, Lloyd K, Lindsey R, Reed R. 1998. Osteopontin stimulates a subpopulation of quiescent human prostate epithelial cells with high proliferative potential to divide in vitro. Prostate 35: 83-94.
26. Ellerhorst J, Nguyen T, Cooper DN, Lotan D, Lotan R. 1999. Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype. Int J Oncol 14:217-224.
27. Ellis WJ, Pfitzenmaier J, Colli J, Arfman E, Lange PH, Vessella RL. 2003. Detection and isolation of prostate cancer cells from peripheral blood and bone marrow. Urology 61:277-281.
28. Evers EE, Zondag GC, Malliri A, Price LS, ten Klouster JP, van der Kammen RA, Collard JG. 2000. Rho family proteins in cell adhesion and cell migration. Eur J Cancer 36:1269-1274.
29. Ewing J. 1928. "A treatise on tumors." Philadelphia: WB Saunders Company.
30. Festuccia C, Bologna M, Gravina GL, Guerra F, Angelucci A, Villanova I, Millimaggi D, Teti A. 1999a. Osteoblast conditioned media contain TGFβ1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components. Int J Cancer 81: 395-403.
31. Festuccia C, Giunciuglio D, Guerra F, Villanova I, Angelucci A, Manduca P, Teti A, Albini A, Bologna M. 1999b. Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and matrigel invasion. Oncol Res 11: 17-31.
32. Fidler IJ. 2002. The organ microenvironment and cancer metastasis. Differentiation 70:498-505.
33. Fornaro M, Tallini G, Bofetiado CJ, Bosari S, Languino LR. 1996. Down-regulation of beta 1C integrin, an inhibitor of cell proliferation, in prostate carcinoma. Am J Pathol 149:765-773.
34. Fornaro M, Manzotti M, Tallini G, Slear AE, Bosari S, Ruoslahti E, Languino LR. 1998. Beta1C integrin in epithelial cells correlates with a nonproliferative phenotype: forced expression of beta1C inhibits prostate epithelial cell proliferation. Am J Pathol 153:1079-1087.
35. Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B. 2002. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer 87:635-644.
36. Geng JG, Bevilacqua MS, Moore KL, McIntyre TM, Prescott SM, Kim JM, Bliss GA, Zimmerman GA, McEver RP. 1990. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 343:757-760.
37. Glinsky VV, Huflejt ME, Glinsky GV, Deutscher SL, Quinn TP. 2000. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on β-galactoside- mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res 60:2584-2588.
38. Glinsky VV, Glinsky GV, Rittenhouse-Olson K, Huflejt ME, Glinskii OV, Deutscher SL, Quinn TP. 2001. The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res 61:4851-4857.
39. Glinsky VV, Glinsky GV, Glinskii OV, Huxley VH, Turk JR, Mossine VV, Deutscher SL, Pienta KJ, Quinn TP. 2003. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res 63:3805-3811.
40. Greenberg DL, Mize GJ, Takayama TK. 2003. Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells. Biochemistry 42: 702-709.
41. Hamdy FC, Autzen P, Robinson MC, Home CH, Neal DE, Robson CN. 1997. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue. Cancer Res 57:4427-4431.
42. Hao J, Jackson L, Calaluce R, McDaniel K, Dalkin BL, Nagle RB. 2001. Investigation into the mechanism of the loss of laminin 5 (α3β 3γ2) expression in prostate cancer. Am J Pathol 158:1129-1135.
43. Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M. 1986. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. J Biol Chem 261:12665-12674.
44. Honn KV, Tang DG. 1992. Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix. Cancer Metastasis Rev 11:353-375.
45. Hood JD, Cheresh DA. 2002. Role of integrins in cell invasion and migration. Nat Rev Cancer 2:91-100.
46. Hullinger TG, McCauley LK, DeJoode ML, Somerman MJ. 1998. Effect of bone proteins on human prostate cancer cell linesin vitro. Prostate 36:14-22.
47. Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES, Scher HI. 1998. A new parameter for measuring metastatic bone involvement by prostate cancer: The Bone Scan Index. Clin Cancer Res 4:1765-1772.
48. Jacob K, Webber M, Benayahu D, Kleinman HK. 1999. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. Cancer Res 59:4453-4457.
49. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. 2003. Cancer statistics, 2003. CA Cancer J Clin 53:5-26.
50. Kamai T, Arai K, Sumi S, Tsujii T, Honda M, Yamanishi T, Yoshida KI. 2002. The Rho/Rho-kinase pathway is involved in the progression of testicular germ cell tumour. BJU Int 89:449-453.
51. Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS. 2001. Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Rev 20:333-349.
52. Khaldoyanidi SK, Glinsky W, Sikora L, Glinskii AB, Mossine VV, Quinn TP, Glinsky GV, Sriramarao P. 2003. MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions. J Biol Chem 278:4127-4134.
53. Kiefer JA, Farach-Carson MC. 2001. Type I collagen-mediated proliferation of PC-3 prostate carcinoma cell line: implications for enhanced growth in the bone microenvironment. Matrix Biol 20:429-437.
54. Kim YJ, Borsig L, Varki NM, Varki A. 1998. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A 95:9325-9330.
55. Kjoller L, Hall A. 1999. Signaling to Rho GTPases. Exp Cell Res 253:166-179.
56. Kostenuik PJ, Sanchez-Sweatman O, Orr FW, Singh G. 1996. Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the α2β1 integrin. Clin Exp Metastasis 14:19-26.
57. Lehr JE, Pienta KJ. 1998. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J Natl Cancer Inst 90:118-123.
58. Longhurst C, Jennings L. 1998. Integrin-mediated signal transduction. Cell Mol Lif Sci 54:514-526.
59. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC. 1998. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865-873.
60. MacDonald IC, Groom AC, Chambers AF. 2002. Cancer spread and micrometastasis development: Quantitative approaches for in vivo models. Bioessays 24:885-893.
61. x and related carbohydrate antigens in the prostate. Hum Pathol 26:735-739.
62. Mercurio AM, Rabinovitz I, Shaw LM. 2001. The α6β4 integrin and epithelial cell migration. Curr Opin Cell Biol 13:541-545.
63. Meyer T, Hart I. 1998. Mechanisms of tumor metastasis. Eu J Cancer 34:214-221.
64. Mizejewski GJ. 1999. Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 222:124-138.
65. Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, Raz A. 2002. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst 94:1854-1862.
66. Naumov GN, MacDonald IC, Chambers AF, Groom AC. 2001. Solitary cancer cells as a possible source of tumour dormancy? Semin Cancer Biol 11:271-276.
67. Naumov GN, MacDonald IC, Weinmeister PM, Kerkvliet N, Nadkarni KV, Wilson SM, Morris VL, Groom AC, Chambers AF. 2002. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 62:2162-2168.
68. Nobes CD, Hall A. 1995. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53-62.
69. Paget S. 1889. The distribution of secondary gorowths in cancer of the breast. Lancet 1:571.
70. Passaniti A, Isaacs JT, Haney JA, Adler SW, Cujdik TJ, Long PV, Kleinman HK. 1992. Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix. Int J Cancer 51:318-324.
71. Pilch J, Habermann R, Felding-Habermann B. 2002. Unique ability of integrin αvβ3 to support tumor cell arrest under dynamic flow conditions. J Biol Chem 277: 21930-21938.
72. Qi H, Fournier A, Grenier J, Fillion C, Labrie Y, Labrie C. 2003. Isolation of the novel human guanine nucleotide exchange factor Src homology 3 domain-containing guanine nucleotide exchange factor (SGEF) and of C-terminal SGEF, an N-terminally truncated form of SGEF, the expression of which is regulated by androgen in prostate cancer cells. Endocrinology 144:1742-1752.
73. Ridley AJ. 2001. Rho GTPases and cell migration. J Cell Sci 114:2713-2722.
74. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. 1992. The small GTP-binding protein Rac regulates growth factor-induced membrane ruffling. Cell 70:401-410.
75. Romanov VI, Goligorsky MS. 1999. RGD-recognizing integrins mediate interactions of human prostate carcinoma cells with endothelial cells in vitro. Prostate 39: 108-118.
76. Rosol TJ, Tannehill-Gregg SH, LeRoy BE, Mandl S, Contag CH. 2003. Animal models of bone metastasis. Cancer 97: 748-757.
77. Rubin MA, Putzi M, Mucci N, Smith DC, Wojno K, Korenchuk S, Pienta KJ. 2000. Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. Clin Cancer Res 6:1038-1045.
78. Sahai E, Marshall CJ. 2002. Rho-GTPases and cancer. Nat Rev Cancer 2:133-142.
79. Sastry SK, Burridge K. 2000. Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics. Exp Cell Res 261:25-36.
80. Schmelz M, Cress AE, Scott KM, Burger F, Cui H, Sallam K, McDaniel KM, Dalkin BL, Nagle RB. 2002. Different phenotypes in human prostate cancer: α6 or α3 integrin in cell-extracellular adhesion sites. Neoplasia 4:243-254.
81. Scott LJ, Clarke NW, George NJ, Shanks JH, Testa NG, Lang SH. 2001. Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion. Br J Cancer 84:1417-1423.
82. Shen X, Falzon M. 2003. Parathyroid hormone-related protein upregulates integrin expression via an intracrine pathway in PC-3 prostate cancer cells. Regul Pept 113: 17-29.
83. Slack JK, Adams RB, Rovin JD, Bissonette EA, Stoker CE, Parsons JT. 2001. Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Oncogene 20:1152-1163.
84. Somlyo AV, Bradshaw D, Ramos S, Murphy C, Myers CE, Somlyo AP. 2000. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun 269:652-659.
85. Somlyo AV, Phelps C, Dipierro C, Eto M, Read P, Barrett M, Gibson JJ, Burnitz MC, Myers C, Somlyo AP. 2003. Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants. Faseb J 17:223-234.
86. Stoelcker B, Hafner M, Orosz P, Nieswandt B, Mannel DN. 1996. Role of adhesion molecules and platelets in TNF-induced adhesion of tumor cells to endothelial cells: implications for experimental metastasis. J Inflamm 46: 155-167.
87. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. 2002. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62:1832-1837.
88. Tamura Y, Takeuchi Y, Suzawa M, Fukumoto S, Kato M, Miyazono K, Fujita T. 2001. Focal adhesion kinase activity is required for bone morphogenetic protein-Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells. J Bone Miner Res 16:1772-1779.
89. Thalmann GN, Sikes RA, Devoll RE, Kiefer JA, Markwalder R, Klima I, Farach-Carson CM, Studer UE, Chung LW. 1999. Osteopontin: possible role in prostate cancer progression. Clin Cancer Res 5:2271-2277.
90. Thomas BG, Hamdy FC. 2000. Bone morphogenetic protein-6: potential mediator of osteoblastic metastases in prostate cancer. Prostate Cancer Prostatic Dis 3:283-285.
91. Trikha M, Nakada MT. 2002. Platelets and cancer: implications for antiangiogenic therapy. Semin Thromb Hemost 28:39-44.
92. Trikha M, Raso E, Cai Y, Fazakas Z, Paku S, Porter AT, Timar J, Honn KV. 1998. Role of αIIbβ3 integrin in prostate cancer metastasis. Prostate 35:185-192.
93. Udayakumar TS, Chen ML, Bair EL, Von Bredow DC, Cress AE, Nagle RB, Bowden GT. 2003. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 β3 chain and induces cell migration. Cancer Res 63:2292-2299.
94. Varghese HJ, Davidson MT, MacDonald IC, Wilson SM, Nadkarni KV, Groom AC, Chambers AF. 2002. Activated Ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases. Cancer Res 62:887-891.
95. Walz DA, Fenton JW. 1994. The role of thrombin in tumor cell metastasis. Invasion Metastasis 14:303-308.
96. Whitehead IP, Zohn IE, Der CJ. 2001. Rho GTPase-dependent transformation by G protein-coupled receptors. Oncogene 20:1547-1555.
97. Yoneda T. 1998. Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer 34:240-245.
98. Zheng DQ, Woodard AS, Tallini G, Languino LR. 2000. Substrate specificity of αvβ3 integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation. J Biol Chem 275:24565-24574.